Medicube Azelaic Acid Exosome Shot Serum 2000 is the 2000 version of the brand’s azelaic acid spicule ampoule. It combines azelaic acid and 5% niacinamide for a smoother-looking, more balanced complexion while adding lightweight hydration.
Why choose Medicube Azelaic Acid Exosome Shot Serum 2000?
- Texture-focused care: Supports a smoother-looking surface around visible pores.
- Azelaic acid blend: Pairs azelaic acid with 5% niacinamide.
- Oil-balance support: Designed for skin concerned with excess shine.
- 2000 version: The brand’s introductory option within this spicule range.
Is it right for you?
Good for: Combination or blemish-prone skin seeking a spicule product for uneven texture, when you tolerate this type of formula.
If you prefer a conventional serum texture, compare Medicube Azelaic Acid 16 BB Calming Serum.
Good to know: 30 ml · 2000 version · Spicule ampoule · 5% niacinamide · A tingling sensation is possible
Key ingredients: Azelaic acid, niacinamide and the brand’s exosome-spicule blend.
How to use
Patch test first. After cleansing, apply a small amount as the first leave-on step, avoiding the eyes, lips and broken skin. Gently press in and follow with a water-based moisturiser. Begin infrequently and adjust to your skin’s response; use sunscreen daily.
Leave on. If you are new to spicules, the brand advises against combining them with AGE-R devices. Stop if you develop strong or persistent burning, swelling or irritation.
FAQ
What is the price of Medicube Azelaic Acid Exosome Shot Serum 2000 in Bangladesh?
The 30 ml pack is currently ৳2,499 at Euros Belle. Prices may change.
Does “2000” state the azelaic acid percentage?
It identifies this version in the Exosome Shot range. It should not be read as the percentage of azelaic acid.
Is tingling expected?
The spicule particles can cause tingling. Use a small amount and adjust frequency to your tolerance; strong or persistent discomfort is a reason to stop.
Shop more Medicube products or browse all serums and ampoules.





Reviews
There are no reviews yet.